University of Illinois Cancer Center | Strategic Alliance Partners

Latest from University of Illinois Cancer Center


New Surgical and Systemic Approaches Enable Earlier Intervention in CRC With Liver Metastases

October 08, 2021

Shikha Jain, MD, FACP, and Mario Spaggiari, MD, highlight key advancements made in the treatment of patients with colorectal cancer and liver metastases, patient and disease factors to consider for surgical and systemic treatment, and the importance of multidisciplinary care for this population.

Biomarkers Drive ICIs in Colon Cancer

December 14, 2020

December 14, 2020 - Immunotherapy agents have shown efficacy in malignant melanoma, kidney cancer, and non–small cell lung cancer, and investigators are examining the efficacy of checkpoint inhibitors in less immunogenic tumors such as colon cancer, particularly in tumors with high microsatellite instability and deficient mismatch repair genes.

Telehealth Is Here to Stay: Opportunities and Challenges for Cancer Care

October 20, 2020

Oncology practices across the United States have rapidly increased telehealth use in 2020 to mitigate the risk of coronavirus disease 2019 (COVID-19) to patients with cancer who are at particular risk of complications.

New Strategy Boosts Microenvironment to Promote Antitumor Immunity in GI Metastases

August 01, 2017

Despite the promise of immunotherapy for treating patients with advanced cancers, the success of using such therapies for progressive gastrointestinal malignancies such as colorectal liver metastases (CRLM) has been limited so far.